COMMUNIQUÉS West-GlobeNewswire
-
Agility Health Announces Resignation of Interim CEO and Chairman
11/04/2018 - 14:34 -
TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel
11/04/2018 - 14:30 -
EyeGate Issued New Patent for Iontophoretic Contact Lens Technology
11/04/2018 - 14:30 -
Oxford Performance Materials Announces Launch of OXPEKK®-SC
11/04/2018 - 14:30 -
Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
11/04/2018 - 14:15 -
Ossur Hf : Q1 2018 Results - Conference call Thursday 26 April at 9:00 CET
11/04/2018 - 14:01 -
Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS
11/04/2018 - 14:00 -
Emblem to Present at the 2018 GMP Securities Cannabis Conference
11/04/2018 - 14:00 -
Emblem Signs 3-Year Supplier Agreement with Fire & Flower
11/04/2018 - 14:00 -
Viracta Initiates Treatment of First Patient in EBV+ Lymphoma Clinical Trial with Tractinostat
11/04/2018 - 14:00 -
Zogenix to Participate in LEERINK Partners CNS Day
11/04/2018 - 14:00 -
Jessica Grossman, M.D., Joins Daré Bioscience Board of Directors
11/04/2018 - 14:00 -
Mesa Labs Reports Transition of its Chief Sales and Marketing Officer
11/04/2018 - 14:00 -
Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at the National Kidney Foundation 2018 Spring Clinical Meetings
11/04/2018 - 14:00 -
Zealand and Roche Diabetes Care enter Phase 3 study collaboration for treatment of congenital hyperinsulinism with dasiglucagon
11/04/2018 - 13:55 -
CymaBay Announces Positive New 12-Week and 26-Week Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis at The International Liver Congress™ 2018
11/04/2018 - 13:47 -
Precipio Launches ICE COLD-PCR™ Research Access Program for Cancer Centers
11/04/2018 - 13:37 -
Cutera, Inc. to Announce First Quarter 2018 Results
11/04/2018 - 13:30 -
Nephros Announces $2.9 Million Private Placement
11/04/2018 - 13:30
Pages